Trade BridgeBio Pharma, Inc. - BBIO CFD

Trading Conditions

• Type: CFD
• Spread: 0.13
• Long position overnight funding adjustment: -0.02149%
• Short position overnight funding adjustment: -0.00074%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 70.1
• Open: 71.08
• 1-Year Change: 110.98%
• Day's Range: 68 - 71.08

What is BridgeBio Pharma, Inc. (BBIO)?

BridgeBio Pharma, Inc. is a biotechnology company focused on developing genetic medicines for patients with Mendelian diseases and cancers. The company identifies and advances drug candidates that target the underlying genetic causes of diseases. Its portfolio includes programs in various stages of clinical development, addressing rare and underserved conditions. BridgeBio Pharma operates through a model that integrates research, development, and commercialization activities. It collaborates with academic institutions and industry partners to accelerate therapeutic innovation. The company emphasizes precision medicine approaches to develop treatments tailored to specific genetic profiles. Operating within the biopharmaceutical sector, BridgeBio Pharma navigates regulatory pathways and clinical trials to bring therapies to market. Its mission centers on translating genetic insights into effective medicines.

BridgeBio Pharma, Inc. Stock Price Today: Live Overview

The price today is shaped by active trading, with BridgeBio Pharma, Inc. positioned at $68.62. Price fluctuations today have ranged from $67.95 to $71.78, showing a daily change of 0%.

FAQ: BridgeBio Pharma, Inc. (BBIO)

What is the current price of BBIO stock?

BridgeBio Pharma, Inc.'s current price is $68.62.

Does BBIO pay dividends?

BridgeBio Pharma, Inc. does not pay dividends.

Does BBIO have a formal corporate presence or regional headquarters in the UAE?

BridgeBio Pharma, Inc. operates in the UAE only through partners and distributors without an official office or subsidiary.

What is BBIO best known for?

BridgeBio Pharma, Inc. is most famous for its development of genetic disease therapies.

What assets are typically shown together with BBIO?

Commonly shown alongside BBIO: L&G Multi, Vanguard FTSE North America UCITS ETF, Merck & Co Inc